- In Vivo Originals
- Featured Topics
Leadership
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
-
Interviews
Helping Organizations Deliver On KPIs And Giving Staff A Voice
By Ashley YeoImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
-
Analysis
South Korea Sees Pharma Leadership Transition
By Mainbayar BadarchLeadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.
-
Interviews
Keys To Success: Maniacal Focus And Adaptive Readiness
By David WildWith an engineer’s mind, Jason Park, CEO of Empress Therapeutics, has a unique take on problem solving for fundraising and the value of being a platform company focused on small molecules.
-
Interviews
Bringing The Circular Economy Sharply Into Focus For Healthtechs
By Ashley YeoAddie MacGregor, at the Association of British HealthTech Industries, guides and advises an industry eager to comply but in search of direction, on matters of environmental sustainability for health care technology manufacturers.
-
Interviews
Investing Is A People Business, Says LifeArc’s Clare Terlouw
By Ashley YeoSuccess in life sciences venture funding requires drive and speed, says In Vivo Rising Leader, Clare Terlouw. But there is more to it than that.
-
Interviews
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
By Barnaby Pickering2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.
-
News
In Vivo's 2024 Rising Leaders At A Glance
By Lucie Ellis-TaittTop 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
-
Analysis
In Vivo’s 2024 Rising Leaders
By Lucie Ellis-TaittThe fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.
-
Data
Execs On The Move: February 2024
By Barnaby PickeringAn interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
-
Analysis
Rising Up In Biopharma: Optimism, AI And Perseverance
By In Vivo TeamAhead of In Vivo’s 2024 Rising Leaders list being revealed in April, a panel of biopharma leaders discussed industry trends and biopharma career stories at BIO-Europe Spring.
-
Interviews
Stelo Launch And Dispelling GLP-1s: Dexcom’s Sayer Speaks
By Barnaby PickeringDexcom’s CEO, Kevin Sayer, ahead of this year’s Advanced Technologies & Treatments for Diabetes conference, shared an update on the company’s recent news, future strategy and where he feels the market is headed.
-
Interviews
20 Voices: What Does 2024 Hold For Biopharma?
By Eleanor Malone20 executives in the biopharma industry outline their view of key trends this year. A selection of commentary from a broad industry survey by Scrip.
-
Interviews
International Women’s Day – An Opportunity To Consider Some Of The Shared And Disparate Challenges Faced By Women In Our Sector
By Barnaby PickeringFriday, 8 March is International Women’s Day, and to celebrate, Citeline spoke to female leaders from across the medtech sector about their experiences as women, women-specific issues that technology can address, and how they can empower others to reach similar – or even greater – levels of success. Take a look at some interview snapshots below:
-
Interviews
Finding Value Left On The Shelf: Karuna Case Study
By Lucie Ellis-TaittPureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
-
Data
Execs On The Move: January 2024
By Barnaby PickeringAn interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
-
Interviews
Climate Compliance For Medtech Businesses: ‘Tactical Changes Are Not Enough’
By Ashley YeoHealth care businesses seeking to reconcile positive climate action with business growth must combine long-term thinking and short-term actions. Only then will they achieve internal and external sustainability goals, says Robert Metzke, Royal Philips’ SVP and global head of sustainability.
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.